Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presença de fatores de risco
- exantema maculopapular
- febre
- artralgias
- linfadenopatia
- imunização incompleta
Fatores de risco
- imunização incompleta
- exposição a contato infeccioso
- viagem internacional
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- IgM anti-rubéola salivar
- sorologia
- Hemograma completo
Investigações a serem consideradas
- cultura viral
- reação em cadeia da polimerase via transcriptase reversa (RT-PCR)
Algoritmo de tratamento
Colaboradores
Autores
Elisabeth Adderson, MD
Associate Member
St. Jude Children's Research Hospital
Associate Professor of Pediatrics
University of Tennessee Health Sciences Center
Memphis
TN
Declarações
EA declares that she has no competing interests.
Revisores
Elizabeth Barnett, MD, FAAP
Director of International Clinical Maxwell Finland Laboratory for Infectious Diseases
Boston Medical Center
Associate Professor of Pediatrics
Boston University School of Medicine
Boston
MA
Declarações
EB has received research grant support from Sandipasteen and Intercell and received an honorarium to attend a meeting sponsored by Novartis. She receives royalties from the sale of a book she edited.
Suzanne M. Garland, MBBS, MD, FRCPAm FAChSHM, FRANZCOG ad eundem
Director of Microbiological Research
Head of Clinical Microbiology and Infectious Diseases
Royal Women's Hospital
Senior Consultant of Microbiology
Royal Children's Hospital
Professor
Faculty of Medicine, Dentistry and Health
Department of Obstetrics and Gynaecology
University of Melbourne
Melbourne
Australia
Declarações
SMG has received advisory board fees and grant support from Commonwealth Serum Laboratories and GlaxoSmithKline, and lecture fees from Merck and GSK. SMG has received funding through her institution to conduct HPV vaccine studies for MSD and GSK.
Robert S. Duszak, OD, FAAO
Co-Director of Residency Program and Consulting Staff
Philadelphia Veterans Affairs Medical Center
Consulting Staff
Nemours Health Clinic & Mayfair Eye Associates
Adjunct Clinical Faculty
Pennsylvania College of Optometry
Salus University
Philadelphia
PA
Declarações
RSD declares that he has no competing interests.
Referências
Principais artigos
Centers for Disease Control and Prevention. Rubella (German measles, three-day measles). Dec 2020 [internet publication].Texto completo
Centers for Disease Control and Prevention. Yellow Book 2024. Section 5: travel-associated infections and diseases - rubella. May 2023 [internet publication].Texto completo
McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.Texto completo Resumo
Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2025. Nov 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older, United States, 2025. Nov 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. Rubella/German measles: 2013 case definition. 2013 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível aqui.
O uso deste conteúdo está sujeito ao nosso aviso legal